✦ LIBER ✦

9027 Patient-derived tumourgrafts of non-small cell lung cancer (NSCLC) as models for the identification of predictive biomarkers for classical and targeted therapies

✍ Scribed by Fichtner, I.; Rolff, J.; Merk, J.; Soong, R.; Lamich, A.; Rivera, M.; Becker, M.; Hoffmann, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishment of patient-derived non-sma

✍ Xu-chao Zhang, Jingchuan Zhang, Ming Li… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 344 KB

Phase II trial of the multi-targeted ant

✍ Rusthoven, J.; Eisenhauer, E.; Butts, C.; Gregg, R.; Dancey, J.; Fisher, B.; Igl 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Patient and Institutional Predictors of

✍ Sher, D.J.; Liptay, M.J.; Fidler, M.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

P-362 Role of mitogen-activated protein

✍ Cappuzzo, Federico; Gregorc, Vanesa; Iombardo, Laura; Magrini, Elisabetta; Cance 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

9000 ORAL Epidermal Growth Factor Recept

✍ O'Bvrne, K.; Paz-Ares, L.; Pereira, J.R.; von Pawel, J.; Ramlau, R.; Störkel, S. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

P-3 A phase II trial of the combination

✍ Winegarden, Jerome D.; Rudin, Charles M.; Mauer, Ann M.; Hoffman, Philip; Szeto, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 338 KB